IUPAC Name :

N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;hydrochloride

CAS Number :   56296-78-7

Structural Formula :

Cadila Pharmaceuticals, Fluoxetine HCL, API

Molecular Weight :  78  g/mol

Molecular Formula :   C17H19ClF3NO

Features of the API:

  • Highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
  • Manufactured in an USFDA, WHO GMP, ISO 9001, OHSAS 18001 approved site.
  • Available in standard pack size of 25 Kgs Net packed in HDPE Carbouys.

Mechanism of Action :

  • Fluoxetine has been shown to selectively inhibit the reuptake of serotonin (5-HT) at the presynaptic neuronal membrane.
  • Fluoxetine elicits antidepressant effect by inhibiting serotonin re-uptake in the synapse by binding to the re-uptake pump on the neuronal membrane to increase its availability and enhance neurotransmission.
  • Fluoxetine-induced inhibition of serotonin reuptake causes increased synaptic concentrations of serotonin in the CNS, resulting in numerous functional changes associated with enhanced serotonergic neurotransmission.
Array
(
    [PHPSESSID] => 19d3bdaebbc54d0a14c740df67fb16d0
)